Status:

COMPLETED

Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsors:

Pediatric Heart Network

Conditions:

Heart Defects, Congenital

Heart Failure, Congestive

Eligibility:

All Genders

Up to 45 years

Phase:

PHASE3

Brief Summary

This study will evaluate the efficacy and safety of administering an angiotensin converting enzyme inhibitor (ACE-I) (enalapril) to infants with a functional single ventricle. The study will also comp...

Detailed Description

BACKGROUND: Growth impairment is common in infants and children with congenital heart disease, most often in the presence of congestive heart failure and/or cyanosis. Growth failure is noted in many ...

Eligibility Criteria

Inclusion

  • Less than or equal to 45 days of age
  • Age greater than 1 week if born at 35 weeks gestation
  • Single ventricle physiology
  • Stable systemic and pulmonary blood flow
  • Planned Glenn shunt surgery (or variant known as hemi-Fontan)

Exclusion

  • Birth weight less than or equal to 2.5 kg if gestational age is greater than or equal to 38 weeks
  • Birth weight less than the 10th percentile for gestational age if gestational age is 35 to 37 weeks
  • Less than 35 weeks gestation
  • Anatomic diagnosis of pulmonary atresia with intact ventricular septum
  • Less than 3 days after palliative cardiac surgical procedure, if performed
  • Aortic oxygen saturation less than 65%
  • Current mechanical ventilatory support
  • Current intravenous inotropic support
  • Creatinine greater than 1.0 mg/dL
  • Absolute neutrophil count less than 1,000 cells/mL
  • Chromosomal or recognizable phenotypic syndrome of noncardiac congenital abnormalities associated with growth failure (e.g., Trisomy 21, Noonan's syndrome, Turner's syndrome)
  • Prior ACE inhibitor use for greater than 7 consecutive days

Key Trial Info

Start Date :

August 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2008

Estimated Enrollment :

230 Patients enrolled

Trial Details

Trial ID

NCT00113087

Start Date

August 1 2003

End Date

July 1 2008

Last Update

September 28 2010

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

Children's Hospital Boston

Boston, Massachusetts, United States, 02115

2

Columbia College of Physicians and Surgeons

New York, New York, United States, 10032

3

Duke University Medical Center

Durham, North Carolina, United States, 27710

4

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229